United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option
Rhea-AI Filing Summary
United Therapeutics Corporation submitted a Form 144 notice to sell 1,300 shares of Common Stock via a stock option exercise to be effected on 03/30/2026. The filing lists prior open-market dispositions by Christopher Causey totaling multiple transactions in January–March 2026.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 144 regulatory
Stock Option Exercise financial
Issuer regulatory
FAQ
What does UTHR's Form 144 say about the sale?
Who is the selling party named in the Form 144 for UTHR?
How large are the recent transactions disclosed in the filing?
Does the Form 144 state who receives proceeds from the sale?